Elevation Oncology Inc (ELEV)
3.84
+0.15
(+4.06%)
USD |
NASDAQ |
May 24, 16:00
3.83
-0.01
(-0.26%)
Pre-Market: 20:00
Elevation Oncology Price to Book Value: 2.767 for May 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 24, 2024 | 2.767 |
| May 23, 2024 | 2.659 |
| May 22, 2024 | 2.746 |
| May 21, 2024 | 2.688 |
| May 20, 2024 | 2.695 |
| May 17, 2024 | 2.602 |
| May 16, 2024 | 2.602 |
| May 15, 2024 | 2.688 |
| May 14, 2024 | 2.566 |
| May 13, 2024 | 2.551 |
| May 10, 2024 | 2.364 |
| May 09, 2024 | 2.530 |
| May 08, 2024 | 2.580 |
| May 07, 2024 | 2.508 |
| May 06, 2024 | 2.695 |
| May 03, 2024 | 2.666 |
| May 02, 2024 | 2.753 |
| May 01, 2024 | 2.883 |
| April 30, 2024 | 2.558 |
| April 29, 2024 | 2.774 |
| April 26, 2024 | 2.609 |
| April 25, 2024 | 2.627 |
| April 24, 2024 | 2.796 |
| April 23, 2024 | 3.113 |
| April 22, 2024 | 2.919 |
| Date | Value |
|---|---|
| April 19, 2024 | 2.738 |
| April 18, 2024 | 2.890 |
| April 17, 2024 | 2.984 |
| April 16, 2024 | 3.164 |
| April 15, 2024 | 3.192 |
| April 12, 2024 | 3.224 |
| April 11, 2024 | 3.367 |
| April 10, 2024 | 3.136 |
| April 09, 2024 | 3.210 |
| April 08, 2024 | 3.163 |
| April 05, 2024 | 3.347 |
| April 04, 2024 | 3.449 |
| April 03, 2024 | 3.524 |
| April 02, 2024 | 3.497 |
| April 01, 2024 | 3.401 |
| March 28, 2024 | 4.554 |
| March 27, 2024 | 4.447 |
| March 26, 2024 | 4.438 |
| March 25, 2024 | 4.065 |
| March 22, 2024 | 3.994 |
| March 21, 2024 | 4.003 |
| March 20, 2024 | 3.852 |
| March 19, 2024 | 3.906 |
| March 18, 2024 | 3.870 |
| March 15, 2024 | 3.897 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2293
Minimum
Sep 22 2022
4.554
Maximum
Mar 28 2024
1.077
Average
0.6383
Median
Feb 10 2022
Price to Book Value Benchmarks
| Merrimack Pharmaceuticals Inc | 1.010 |
| TG Therapeutics Inc | 16.13 |
| Mersana Therapeutics Inc | 10.41 |
| Equillium Inc | 2.340 |
| Monopar Therapeutics Inc | 1.471 |
Price to Book Value Related Metrics
| Price | 3.84 |
| Earnings Yield | -25.52% |
| Market Cap | 209.81M |